Crossmark

The Role of GLP-1 Receptor Agonists in Rheumatic Diseases: Cardioprotective Potentials, Anti-Inflammatory Effects, and Future Emerging Therapeutic Applications

Crossref DOI link: https://doi.org/10.1007/s11936-025-01124-z

Published Online: 2025-09-20

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Abdelnabi, Mahmoud

Chaisrimaneepan, Nattanicha

Castillo-Rodriguez, Cristian

Eshak, Nouran

Sullivan, Megan

Ibrahim, Ramzi

Pham, Hoang Nhat

Farina, Juan

Ayoub, Chadi

Nagaraja, Vivek

Arsanjani, Reza
License Information

Text and Data Mining valid from 2025-09-20

Version of Record valid from 2025-09-20
More Information

Article History

Received: 6 August 2025

Accepted: 8 September 2025

First Online: 20 September 2025

Declarations

:

: All the authors declare no conflict of interest.

: This article does not contain any studies with human or animal subjects performed by any of the authors.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below